Kidney Biopsy Market
Report ID: SQMIG35A4212
Report ID: SQMIG35A4212
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35A4212 |
Region:
Global |
Published Date: July, 2026
Pages:
157
|Tables:
143
|Figures:
78
Global Kidney Biopsy Market size was valued at USD 2.36 Billion in 2024 and is poised to grow from USD 2.47 Billion in 2025 to USD 3.47 Billion by 2033, growing at a CAGR of 4.7% during the forecast period (2026-2033).
Global market for kidney biopsy includes equipment, disposables, and additional services used in taking kidney tissues to diagnose acute kidney injury, glomerulonephritis, and organ rejection after transplant. It is significant because kidney biopsy can provide histological information to guide treatment and therefore decrease risks and health care expenditures. Its use was restricted to tertiary hospitals only due to invasiveness of the process and necessity to have experienced pathologists, but development of ultrasound guided biopsy needles at the beginning of 2000s increased availability in community clinics as well. Due to rapid increase in chronic kidney diseases globally, physicians are using more kidney biopsies.
The driver that will propel the growth of the kidney biopsy market is the use of precise medicine in nephrology with the help of biomarkers based on tissue. With the emergence of new immunosuppressive agents and biologics, doctors require a histological confirmation of the phenotype of diseases to select the therapy regimen; this increases the number of procedures performed. With the increase in reimbursements linked with biopsy diagnostics, hospitals acquire technologies. A university hospital introduced a robotic needle guidance device, reducing complication rates by 30% and decreasing the time of hospital stay, encouraging payers to expand coverage.
How is AI Improving Diagnostic Accuracy in the Kidney Biopsy Market?
AI technology is helping improve the diagnostic accuracy of the kidney biopsy market by automating pathology workflow, minimizing the variability in interpretation, and helping detect renal diseases at an early stage. AI-based digital pathology software helps analyze images from the biopsy slides to diagnose any glomerular, tubular, interstitial, or vascular problems with more accuracy, whereas machine learning helps quantify the degree of fibrosis, inflammation, and sclerosis to provide standardized measurements. Machine learning helps accurately classify diseases like IgA nephropathy, lupus nephritis, diabetic nephropathy, and FSGS. Using AI technology, the information obtained from biopsies can be integrated with clinical, laboratory, genetic, and biomarkers data to help take personalized treatment decisions.
Market snapshot - (2026-2033)
Global Market Size
USD 2.36 Billion
Largest Segment
Percutaneous Kidney Biopsy
Fastest Growth
Transjugular Kidney Biopsy
Growth Rate
4.7% CAGR
To get more insights on this market click here to Request a Free Sample Report
The global kidney biopsy market is segmented by procedure type, product, guidance technique, application, end user and region. Based on procedure type, the market is segmented into Percutaneous Kidney Biopsy, Open (Surgical) Kidney Biopsy, and Transjugular Kidney Biopsy. Based on product, the market is segmented into Biopsy Needles, Biopsy Guidance Systems, and Biopsy Kits & Accessories. Based on guidance technique, the market is segmented into Ultrasound-Guided and Computed Tomography (CT)-Guided. Based on application, the market is segmented into Native Kidney Biopsy and Transplant Kidney Biopsy. Based on end user, the market is segmented into Hospitals, Specialty Clinics, Ambulatory Surgical Centers (ASCs) and Academic & Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Percutaneous kidney biopsy segment is the market leader owing to its less intrusive and outpatient-friendly nature, which suits the preference of clinicians for procedures that involve lesser patient pain and faster recovery periods. Its simplicity of execution through the use of ordinary imaging equipment contributes to its popularity. Consequently, hospitals and other clinical facilities adopt this technique, contributing to its leading position in the kidney biopsy market.
On the other hand, transjugular kidney biopsy segment is experiencing fast-paced growth, as medical practitioners are on the lookout for an alternative procedure that would be safer for obese patients and those suffering from coagulopathy. The procedure enables entry into the renal cortex through the venous route and minimizes the risk of bleeding.
The biopsy guidance systems segment prevails as it combines cutting-edge imaging technology, navigation, and automation to ensure accuracy and prevent complications. Through offering live feedback, this equipment allows clinicians to reach lesions easily, ensuring minimal passes and pain for the patients. This capability to bring standardization into a process ensures provider satisfaction, resulting in adoption of the solution by a wide range of healthcare facilities, including general hospitals and specialized centers.
Conversely, the biopsy kits and accessories segment exhibits the highest rate of growth due to the combination of complementary solutions by the manufacturers to offer integrated kits. This allows streamlining of the process, which attracts cost-conscious organizations.
To get detailed segments analysis, Request a Free Sample Report
The leadership of North America is attributed to an array of factors, including superior healthcare infrastructure, presence of vibrant research environments, and sound reimbursement policies that encourage sophisticated diagnostics. There is an abundance of premier medical schools that are involved in innovations in biopsy and pathology. There are high levels of insurance cover which ensures that patients gain access to health services. The favorable regulatory environment facilitatesspeedy adoption of new technologies. The cooperation between the industry and the medical institution drives innovation in renal diagnostics.
United States Kidney Biopsy Market is influenced by a well-developed ecosystem of tertiary care centers and an early adopter environment. Leading academic hospitals practice precision medicine, thus increasing the need for advanced sampling technologies and digital pathology platforms. Fully developed insurance coverage and an active clinical trial environment drive the evolution of safety and efficacy of kidney biopsy procedures.
Market for Kidney Biopsy in Canada depends on public funding in the country due to its emphasis on the availability of advanced diagnostics through a fair distribution of health care. There is collaboration between the health authorities and universities in adopting the latest technology in kidney biopsies, which is aligned with the trend of streamlining workflow solutions in large hospitals.
The rapid growth in Europe is being fueled by the presence of harmonized standards which make it easier for innovative biopsy instruments and digital pathology systems to enter into the market. Clinical awareness regarding early detection of diseases such as kidney diseases has increased the demand for such systems among many patients. Health technology infrastructure investments in the region are helping to implement minimally invasive techniques, while academic partnerships are aiding information exchange.
Germany’s Kidney Biopsy Market profits from the presence of many centers for kidney treatment with an emphasis on highly accurate diagnosis processes. Effective reimbursement systems make it profitable to adopt image-guided procedures, while Germany’s excellent engineering culture makes manufacturers produce highly sophisticated equipment. Hospital and scientific cooperation help to improve results continually.
The Kidney Biopsy Market in the UK is expanding quickly owing to the emphasis placed by national health services on early identification of kidney diseases. Telepathology and AI-driven diagnostics help speed up the process of diagnosis. Reduction in length of hospital stay through policy measures encourages minimally invasive procedures, while academic health sciences centers conduct clinical trials for new biopsy methods.
Kidney Biopsy Market in France is turning out to be a vibrant market because of the emphasis on preventative nephrology through public health programs. Hospitals in the region have been taking up portable imaging techniques to extend the scope in urban as well as rural areas. Collaboration between biotech companies and university laboratories brings about innovations in biopsy needle technology and tissue analysis.
Asia Pacific has gained its strength through the growing demands for its clinical services, which have been caused by an increase in the number of cases of chronic kidney diseases, along with increased awareness about health issues. Governments have been spending on upgrading their hospitals' infrastructures to promote image-guided and minimally invasive biopsy techniques. Increased proficiency of interventional radiologists and pathologists improves procedure performance, whereas technology transfer and local production build the robustness of the market.
Market for Kidney Biopsies in Japan features an intense focus on precision and patient safety. Imaging techniques are used extensively to enhance biopsy procedures, and careful clinical practices ensure accurate diagnoses. The partnership of medical devices manufacturers and research organizations helps develop precise needle technology, in line with the country's policies for the care of its aging population.
Market for Kidney Biopsy in South Korea is supported by fast digital health uptake and positive regulation. Hospitals have an emphasis on minimally invasive procedures, and the use of artificial intelligence systems in pathology analysis is helping to increase effectiveness. Academic hospitals are instrumental in performing clinical trials and introducing new biopsy products in line with emerging needs.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Rising Prevalence of Kidney Diseases
The rising incidence of chronic kidney diseases and their associated conditions make histopathology assessment essential, leading to the dependence of doctors on kidney biopsies to make a proper diagnosis and decide about the treatment options. With the aging of the population and various other aspects of life that are causing damage to kidneys, there is an increased need for quick tissue assessment to make effective decisions, and this contributes to the growth of the market.
Advancements in Diagnostic Imaging Techniques
Advancements in technology regarding ultrasonic scans, MRI scans, and CT scans have increased the accuracy of locating lesions in kidneys, making the procedure safer and giving doctors more confidence to carry out biopsies. The real-time guiding systems help visualize the structures of the kidney better and enable precise tissue sampling with minimum chances of complications. This leads to improved efficiency and decreased time taken in the procedures, thus encouraging greater uptake of biopsy procedures in educational and community settings, driving market growth.
High Cost of Biopsy Equipment
High initial costs associated with biopsy needles, imaging devices, and processing machines represent an economic barrier for health-care organizations, especially in developing countries that have budgetary constraints regarding the procurement of new technology. The high cost may lead to delayed procurement decision making and result in the use of outdated equipment. Hence, economic factors become a barrier to the adoption of innovative biopsy solutions, thus limiting the growth of the market. Health-care organizations may also incur maintenance and training costs associated with the use of biopsy platforms.
Limited Access to Skilled Pathologists
An expert evaluation of kidney biopsy tissue demands pathology skills that are not readily available in many areas, which results in diagnostic delays and even misdiagnoses. Relying on external labs entails several difficulties and involves doubts about the quality of tissue handling and long wait times for analysis results. Such staffing issues impede effective provision of services, reduce the confidence of medical practitioners in biopsy results, and prevent hospitals from extending their biopsy programs, thus limiting market development. Besides, the lack of telepathology systems impedes remote consultations and is a significant deterrent to developing biopsy services in the area.
Request Free Customization of this report to help us to meet your business objectives.
The competitive landscape of the global kidney biopsy market is shaped by strategic M&A activity and partnership deals that accelerate technology integration and geographic reach; recent examples include Cardinal Health’s $1.9 billionacquisition of Solaris Health and multiple nephrology-focused collaborations emerging from the 2026 wave of 26 acquisitions and 28 IPOs, driving rapid adoption of advanced biopsy platforms and digital pathology solutions.
Precision Imaging Integration: The healthcare industry is rapidly moving towards utilizing digital microscopy in combination with image analytics based on artificial intelligence for kidney biopsy assessment. The combination of real-time ultrasound and robotic assistance will minimize sampling errors, whereas pathology software will help digitize slides quickly and carry out remote collaboration. This approach is efficient not only in terms of diagnostics but also in personalizing therapy and minimizing the necessity for repeated procedures. Moreover, the shift to digital workflow is beneficial for research because it ensures effective data exchange.
Decentralized Testing Platforms: Point-of-care renal biopsy kits that are being developed are being augmented by tele-pathology systems, thus expanding the diagnostic capabilities beyond tertiary care centers. It is possible to collect samples from patients using portable devices, and cloud-based slide streaming helps specialist renal pathologists offer their judgments remotely. The decentralization of such systems helps in decreasing turnaround time, patient travel burden, and early diagnosis of the disease in marginalized groups. With changing regulatory standards, more such systems will gain momentum in the future.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global market for kidney biopsies is expected to be driven mainly by the increasing incidences of chronic kidney diseases that compel physicians to get accurate tissue diagnosis, along with the fast development of imaging modalities like ultrasound and CT scans, which make the procedures even more reliable. Percutaneous kidney biopsies are leading the market since they allow carrying out the procedure using a noninvasive technique that is preferred by both medical professionals and patients. North America holds the largest share in this market due to advanced health care infrastructure, favorable reimbursement conditions, and active research efforts. High costs of kidney biopsy devices limit their use, however.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 2.36 Billion |
| Market size value in 2033 | USD 3.47 Billion |
| Growth Rate | 4.7% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Kidney Biopsy Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Kidney Biopsy Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Kidney Biopsy Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Kidney Biopsy Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Kidney Biopsy Market size was valued at USD 2.36 Billion in 2024 and is poised to grow from USD 2.47 Billion in 2025 to USD 3.47 Billion by 2033, growing at a CAGR of 4.7% during the forecast period (2026-2033).
The competitive landscape of the global kidney biopsy market is shaped by strategic M&A activity and partnership deals that accelerate technology integration and geographic reach; recent examples include Cardinal Health’s $1.9 billion acquisition of Solaris Health and multiple nephrology-focused collaborations emerging from the 2026 wave of 26 acquisitions and 28 IPOs, driving rapid adoption of advanced biopsy platforms and digital pathology solutions. 'BD', 'Argon Medical Devices Inc.', 'Cook Medical LLC', 'Merit Medical Systems Inc.', 'Teleflex Incorporated', 'Boston Scientific Corporation', 'Stryker Corporation', 'Medtronic plc', 'Olympus Corporation', 'B. Braun Melsungen AG', 'Hologic Inc.', 'Mammotome', 'Devicor Medical Products Inc.', 'INRAD Inc.', 'Uskan', 'TSK Laboratory', 'Somatex Medical Technologies GmbH', 'Biomedical Srl', 'Gallini Srl', 'Molnlycke Health Care AB'
The increasing prevalence of chronic kidney disease and related disorders drives demand for accurate histopathological assessment, prompting clinicians to rely on kidney biopsies for definitive diagnosis and treatment planning. As patient populations age and lifestyle factors contribute to renal impairment, physicians seek timely tissue evaluation to guide therapeutic decisions, thereby expanding the utilization of biopsy services across hospitals and specialty clinics. These procedures also support clinical research initiatives and enable personalized medicine approaches, reinforcing the overall growth trajectory of the market.
Precision Imaging Integration: Healthcare providers are increasingly adopting high‑resolution digital microscopy and AI‑enhanced image analysis to streamline kidney biopsy evaluation. Real‑time ultrasound guidance coupled with robotic assistance reduces sampling errors, while integrated pathology software enables rapid slide digitization and collaborative review across institutions. These precision imaging capabilities accelerate diagnostic confidence, support personalized treatment planning, and lower repeat‑procedure rates. The shift toward seamless digital workflows also facilitates seamless data sharing for research, fostering innovation in nephrology and strengthening the market’s value proposition for clinicians and patients alike.
Why does North America Dominate the Global Kidney Biopsy Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
